Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 541–550 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 541

    Medicine slug
    erlotinib
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    11
    Source count
    11
    Agreement rate
    1
    Recorded readings

    1. 36.2 hours

      Numeric value
      36.2
      Unit
      hours
      Source records
      11

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 11 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a3b2d622-b4d5-4819-862b-f8fd3adcec6f (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36fa076-e23b-437f-bbd2-0433ce333175 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53cf8868-cfd8-4c6e-ad9d-3171ff1e4d8c (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib tablets 2 nd /3 rd line regimen.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c35e019d-ec34-4e61-9400-a7ae7913e025 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ecafc1e-979a-4aff-a276-18fc0b110491 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4cff04f5-3693-4d87-a9f8-a2b195e3d26e (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 nd line regimen.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d97f401-4853-4a9a-907d-21e8a4d16088 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib tablets 2 nd /3 rd line regimen.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:766baa46-1916-44e8-b599-33017a4194f1 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib tablets 2 nd /3 rd line regimen.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf1e415-4980-462f-8ac2-87979bda149e (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib 2 nd /3 rd line regimen.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4c7353-b81c-4651-8aac-6d15e88145af (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Elimination Erlotinib is eliminated with a median half-life of 36.2 hours in patients receiving the single-agent erlotinib tablets 2 nd /3 rd line regimen.

  2. Projected row 542

    Medicine slug
    erlotinib
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    11
    Source count
    11
    Agreement rate
    1
    Recorded readings

    1. 232 liters

      Numeric value
      232
      Unit
      L
      Source records
      11

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 11 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a3b2d622-b4d5-4819-862b-f8fd3adcec6f (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36fa076-e23b-437f-bbd2-0433ce333175 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53cf8868-cfd8-4c6e-ad9d-3171ff1e4d8c (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c35e019d-ec34-4e61-9400-a7ae7913e025 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ecafc1e-979a-4aff-a276-18fc0b110491 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4cff04f5-3693-4d87-a9f8-a2b195e3d26e (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5d97f401-4853-4a9a-907d-21e8a4d16088 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:766baa46-1916-44e8-b599-33017a4194f1 (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf1e415-4980-462f-8ac2-87979bda149e (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c4c7353-b81c-4651-8aac-6d15e88145af (opens source in a new tab)

        Erlotinib label

        Version not recorded · Effective date not recorded

        Erlotinib has an apparent volume of distribution of 232 liters.

  3. Projected row 543

    Medicine slug
    ertapenem
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 90%

      Numeric value
      90
      Unit
      %
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f74cca2f-e775-4580-acae-3a0c47dd24d9 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b88c0709-33fe-47db-8ae8-8bad6692d5d5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33f3b99b-fa82-42e0-26bf-f49891ae3d22 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:124775ed-1271-4581-be52-b7a08c91283d (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:666c9f33-ea9e-4667-b8bd-f8b1b6b6be51 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44496f7c-8407-4765-9cd6-1daa619a6db6 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:178a0356-4f6c-47fb-9913-f325a3c72f7b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:657855f2-7c92-4aa8-9c3d-51d08e56a09a (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a400707f-763f-43f6-989e-0d2569d822d8 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bd4d41-36f8-4826-a733-a5ad1a531c02 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bcf16f-e0c1-47d1-9852-de898a856f6e (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4da28cb-6725-4fa1-a7b0-e84f408fb36b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32d9f095-ca39-7e22-6264-b54f2daaee57 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eccc96f-4b59-49ee-9997-365a24f59a24 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c398450c-2b72-86a4-e053-2995a90ad1f0 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468105b9-48b3-4477-82c7-e7fb92460e28 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41304b1d-7db4-468a-ab1d-04e56fb50de4 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf3cfa6b-211c-452b-b18b-e462b21e6909 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f725a68c-31a2-482a-9744-19adc47506b5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2398d418-6efc-b4d2-3265-936001df9b8b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean bioavailability is approximately 90%.

  4. Projected row 544

    Medicine slug
    ertapenem
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 4 hours

      Numeric value
      4
      Unit
      hours
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f74cca2f-e775-4580-acae-3a0c47dd24d9 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b88c0709-33fe-47db-8ae8-8bad6692d5d5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33f3b99b-fa82-42e0-26bf-f49891ae3d22 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:124775ed-1271-4581-be52-b7a08c91283d (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:666c9f33-ea9e-4667-b8bd-f8b1b6b6be51 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44496f7c-8407-4765-9cd6-1daa619a6db6 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:178a0356-4f6c-47fb-9913-f325a3c72f7b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:657855f2-7c92-4aa8-9c3d-51d08e56a09a (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a400707f-763f-43f6-989e-0d2569d822d8 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bd4d41-36f8-4826-a733-a5ad1a531c02 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bcf16f-e0c1-47d1-9852-de898a856f6e (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4da28cb-6725-4fa1-a7b0-e84f408fb36b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32d9f095-ca39-7e22-6264-b54f2daaee57 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eccc96f-4b59-49ee-9997-365a24f59a24 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c398450c-2b72-86a4-e053-2995a90ad1f0 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468105b9-48b3-4477-82c7-e7fb92460e28 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41304b1d-7db4-468a-ab1d-04e56fb50de4 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf3cfa6b-211c-452b-b18b-e462b21e6909 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f725a68c-31a2-482a-9744-19adc47506b5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2398d418-6efc-b4d2-3265-936001df9b8b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The mean plasma half-life in healthy young adults is approximately 4 hours and the plasma clearance is approximately 1.8 L/hour.

  5. Projected row 545

    Medicine slug
    ertapenem
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 2.3 hours

      Numeric value
      2.3
      Unit
      hours
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f74cca2f-e775-4580-acae-3a0c47dd24d9 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b88c0709-33fe-47db-8ae8-8bad6692d5d5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33f3b99b-fa82-42e0-26bf-f49891ae3d22 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:124775ed-1271-4581-be52-b7a08c91283d (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 gram daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:666c9f33-ea9e-4667-b8bd-f8b1b6b6be51 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily I.M. administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44496f7c-8407-4765-9cd6-1daa619a6db6 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:178a0356-4f6c-47fb-9913-f325a3c72f7b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily I.M. administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:657855f2-7c92-4aa8-9c3d-51d08e56a09a (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a400707f-763f-43f6-989e-0d2569d822d8 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily I.M. administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bd4d41-36f8-4826-a733-a5ad1a531c02 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 gram daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bcf16f-e0c1-47d1-9852-de898a856f6e (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4da28cb-6725-4fa1-a7b0-e84f408fb36b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32d9f095-ca39-7e22-6264-b54f2daaee57 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eccc96f-4b59-49ee-9997-365a24f59a24 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c398450c-2b72-86a4-e053-2995a90ad1f0 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468105b9-48b3-4477-82c7-e7fb92460e28 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41304b1d-7db4-468a-ab1d-04e56fb50de4 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf3cfa6b-211c-452b-b18b-e462b21e6909 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f725a68c-31a2-482a-9744-19adc47506b5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2398d418-6efc-b4d2-3265-936001df9b8b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        Following 1 g daily IM administration, mean peak plasma concentrations (C max ) are achieved in approximately 2.3 hours (T max ).

  6. Projected row 546

    Medicine slug
    ertapenem
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 0.12 liter/kg

      Numeric value
      0.12
      Unit
      L/kg
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f74cca2f-e775-4580-acae-3a0c47dd24d9 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b88c0709-33fe-47db-8ae8-8bad6692d5d5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33f3b99b-fa82-42e0-26bf-f49891ae3d22 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:124775ed-1271-4581-be52-b7a08c91283d (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (Vss) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:666c9f33-ea9e-4667-b8bd-f8b1b6b6be51 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44496f7c-8407-4765-9cd6-1daa619a6db6 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:178a0356-4f6c-47fb-9913-f325a3c72f7b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:657855f2-7c92-4aa8-9c3d-51d08e56a09a (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a400707f-763f-43f6-989e-0d2569d822d8 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bd4d41-36f8-4826-a733-a5ad1a531c02 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (Vss) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31bcf16f-e0c1-47d1-9852-de898a856f6e (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4da28cb-6725-4fa1-a7b0-e84f408fb36b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:32d9f095-ca39-7e22-6264-b54f2daaee57 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        oximate plasma concentration of <100 micrograms (mcg)/mL to approximately 85% bound at an approximate plasma concentration of 300 mcg/mL.The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8eccc96f-4b59-49ee-9997-365a24f59a24 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c398450c-2b72-86a4-e053-2995a90ad1f0 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468105b9-48b3-4477-82c7-e7fb92460e28 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41304b1d-7db4-468a-ab1d-04e56fb50de4 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf3cfa6b-211c-452b-b18b-e462b21e6909 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f725a68c-31a2-482a-9744-19adc47506b5 (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of age.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2398d418-6efc-b4d2-3265-936001df9b8b (opens source in a new tab)

        Ertapenem label

        Version not recorded · Effective date not recorded

        oximate plasma concentration of <100 micrograms (mcg)/mL to approximately 85% bound at an approximate plasma concentration of 300 mcg/mL.The apparent volume of distribution at steady state (V ss ) of ertapenem in adults is approximately 0.12 liter/kg, approximately 0.2 liter/kg in pediatric patients 3 months to 12 years of age and approximately 0.16 liter/kg in pediatric patients 13 to 17 years of

  7. Projected row 547

    Medicine slug
    escitalopram
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    81
    Source count
    81
    Agreement rate
    1
    Recorded readings

    1. 80%

      Numeric value
      80
      Unit
      %
      Source records
      81

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 81 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:102c3893-4fdc-40b3-bd83-775e292723d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d54a1cf-29cd-c485-e063-6394a90aeba3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e56e8d41-188c-5a6f-e053-2a95a90a70e6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13bb8267-1cab-43e5-acae-55a4d957630a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0de88dad-d54c-4773-a5d6-a705e012973a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d31c02d0-81d9-4aa4-bde9-52135aa5a66d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f435d670-87ff-f226-e053-2a95a90ac0ee (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:900b7a2f-23e7-4c78-bd6e-549bbe09883e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3de8ea-b96b-456b-9336-69380fd2d058 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85b2f57e-53f3-4b93-9128-ad74cc34be4c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc61822a-4058-343c-e053-6294a90af72c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de803217-6d32-4ef8-afe7-02462f37bf0c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53a7e974-9945-4e42-8395-b567bf9f1c4e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31ce0b82-58fe-44f3-8887-c55d8df1b773 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d9ba6c65-22bd-10c4-e053-2995a90ada2e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba6a0c20-4915-4164-a39e-ca67d652cbfd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64de12e0-c35f-4082-b902-ddbaee8158a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d75e3b97-1ead-4e7b-9ae3-3626aede1efd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:575d7755-0518-4d48-bb1a-4ad01321fde7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9b0b3c54-5bbc-4db9-9c69-00dac1347f24 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f75aabf8-f4a1-acd1-e053-6294a90ab9a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da7feb56-5f5a-7487-e053-2995a90a119e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45ed4d16-6358-40a1-9352-319e58f55e5d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d16a7510-c787-4c9b-818b-1ffbcc62b3c3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb30d1c5-2280-465f-84f4-4367ad5f1a31 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d58c448-4a6c-1b7d-e063-6294a90a7d03 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d143ec01-9445-42d5-a259-b0b5a7f9445f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f682f991-1807-176a-e053-2995a90a3dfa (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:068bb338-23f3-4278-958b-c34b40456024 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:155e973a-f4ff-4e5a-b937-09f1e106fe39 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83a642b9-acee-45d3-95a1-52a491b770fd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c00c4d3-8248-4321-adec-03886c0d0f7b (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ca5da44-403b-4c9f-9dde-f5a87866836d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:84b2028d-eff4-434d-b71e-6a3c0812f625 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb3f9af4-5bb4-48a8-b972-ff92cff1ea01 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f914fec5-4ce7-794d-e053-6294a90a7cc5 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ffc6ec3-830f-46bc-9b3f-7c42cefa39b2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1df5c652-7bad-4b07-b33b-333071bc2670 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a489600b-6ae0-edb7-e053-2a95a90a7d00 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c842ec12-8792-47a9-82ad-9edf99e549ba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:735a138b-fff3-4ed0-8a51-9090cf88ba30 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09894a38-4e3a-475d-96cd-c6c8ed87869a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:362327ce-2dde-f657-e063-6394a90a0b63 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1285841d-d9f8-49c6-9456-bf51c8e37271 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3a3e36-fb2f-4d9b-bbcf-423bd97c9f88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5088d6cd-ec13-384d-e063-6394a90aee05 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0ff752d-cb30-4131-a7d6-cd66d8a47b1a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83fb7392-087d-4284-b27b-fa192e49dc21 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d2f83c1-8ffe-48f3-a084-150289001743 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4508226c-5623-41d3-8916-5f94ffdb8839 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0344290-6e12-46c4-a11c-5347a770adbe (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16a07596-2a89-4897-a829-529452ceb1e8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbe97b5-da68-4fff-929a-240dd705fe6f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4966fd83-ee96-4f87-beb1-dd40d70de445 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f81e3858-f01e-1df6-e053-6394a90aef4f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9f52332-8616-19d8-e053-2995a90ad753 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b7b0a6-481b-1f6f-e053-2a95a90a2d04 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3965ca55-a5ff-4ed0-940c-363d74683fab (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fb28a40-037a-49a0-b418-6c6841885cf4 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dabf8bc0-5de6-edce-e053-2995a90a73c9 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ef807d2-5d66-40c2-be3e-ff6176a35295 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c68f89b-1d34-4735-9631-817f012935d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43eb9e4f-1a46-46f7-9e9d-43e866963b37 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b2ec266-be5b-9265-e063-6294a90a10e3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20281fe6-7db9-4b33-8418-b25e6a5404ca (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b3b385-658d-5918-e053-2a95a90afcba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6cacd68-0f55-deb9-e053-6294a90aa266 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4d5c3142-b850-49b9-9f5c-81fe15ea7bfb (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e88bc86-d5e2-50ca-e053-2995a90a0f0e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:addccf96-cc60-6045-e053-2a95a90aaac0 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4a12048-181e-45ed-a382-f53096d1b689 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d125ea4-5430-5b4e-e054-00144ff88e88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6fbd554-9da7-40fd-87a5-2c4af2aa3e6c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76a8aedd-7853-4d3f-9a00-f8222f55bea8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9ddd1f24-3ebd-4307-bb23-6acd742cd140 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83510549-bd47-4969-aba0-c149a0fbb7f3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a645652-ae1f-3811-e054-00144ff8d46c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0458445b-e431-4c82-86b8-90373813c10a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0401570-a3b0-bef2-7365-c23dc952b8b6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a3f4bc9-cd6e-49b1-ab6c-982b70f51fd2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eef1c681-1972-4c3f-b4ba-cbb3388f397a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Absorption The absolute bioavailability of citalopram is about 80% relative to an intravenous dose.

  8. Projected row 548

    Medicine slug
    escitalopram
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    81
    Source count
    81
    Agreement rate
    1
    Recorded readings

    1. 27-32 hours

      Numeric value
      27
      Unit
      hours
      Source records
      81

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 81 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:102c3893-4fdc-40b3-bd83-775e292723d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d54a1cf-29cd-c485-e063-6394a90aeba3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e56e8d41-188c-5a6f-e053-2a95a90a70e6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13bb8267-1cab-43e5-acae-55a4d957630a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0de88dad-d54c-4773-a5d6-a705e012973a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d31c02d0-81d9-4aa4-bde9-52135aa5a66d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f435d670-87ff-f226-e053-2a95a90ac0ee (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:900b7a2f-23e7-4c78-bd6e-549bbe09883e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3de8ea-b96b-456b-9336-69380fd2d058 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85b2f57e-53f3-4b93-9128-ad74cc34be4c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc61822a-4058-343c-e053-6294a90af72c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de803217-6d32-4ef8-afe7-02462f37bf0c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53a7e974-9945-4e42-8395-b567bf9f1c4e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31ce0b82-58fe-44f3-8887-c55d8df1b773 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d9ba6c65-22bd-10c4-e053-2995a90ada2e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba6a0c20-4915-4164-a39e-ca67d652cbfd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64de12e0-c35f-4082-b902-ddbaee8158a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d75e3b97-1ead-4e7b-9ae3-3626aede1efd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:575d7755-0518-4d48-bb1a-4ad01321fde7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9b0b3c54-5bbc-4db9-9c69-00dac1347f24 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f75aabf8-f4a1-acd1-e053-6294a90ab9a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da7feb56-5f5a-7487-e053-2995a90a119e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45ed4d16-6358-40a1-9352-319e58f55e5d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d16a7510-c787-4c9b-818b-1ffbcc62b3c3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb30d1c5-2280-465f-84f4-4367ad5f1a31 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d58c448-4a6c-1b7d-e063-6294a90a7d03 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d143ec01-9445-42d5-a259-b0b5a7f9445f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f682f991-1807-176a-e053-2995a90a3dfa (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:068bb338-23f3-4278-958b-c34b40456024 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:155e973a-f4ff-4e5a-b937-09f1e106fe39 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83a642b9-acee-45d3-95a1-52a491b770fd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c00c4d3-8248-4321-adec-03886c0d0f7b (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ca5da44-403b-4c9f-9dde-f5a87866836d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:84b2028d-eff4-434d-b71e-6a3c0812f625 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb3f9af4-5bb4-48a8-b972-ff92cff1ea01 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f914fec5-4ce7-794d-e053-6294a90a7cc5 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ffc6ec3-830f-46bc-9b3f-7c42cefa39b2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1df5c652-7bad-4b07-b33b-333071bc2670 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a489600b-6ae0-edb7-e053-2a95a90a7d00 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c842ec12-8792-47a9-82ad-9edf99e549ba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:735a138b-fff3-4ed0-8a51-9090cf88ba30 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09894a38-4e3a-475d-96cd-c6c8ed87869a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:362327ce-2dde-f657-e063-6394a90a0b63 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1285841d-d9f8-49c6-9456-bf51c8e37271 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3a3e36-fb2f-4d9b-bbcf-423bd97c9f88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5088d6cd-ec13-384d-e063-6394a90aee05 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0ff752d-cb30-4131-a7d6-cd66d8a47b1a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83fb7392-087d-4284-b27b-fa192e49dc21 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d2f83c1-8ffe-48f3-a084-150289001743 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4508226c-5623-41d3-8916-5f94ffdb8839 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0344290-6e12-46c4-a11c-5347a770adbe (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16a07596-2a89-4897-a829-529452ceb1e8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbe97b5-da68-4fff-929a-240dd705fe6f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4966fd83-ee96-4f87-beb1-dd40d70de445 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f81e3858-f01e-1df6-e053-6394a90aef4f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9f52332-8616-19d8-e053-2995a90ad753 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b7b0a6-481b-1f6f-e053-2a95a90a2d04 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3965ca55-a5ff-4ed0-940c-363d74683fab (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fb28a40-037a-49a0-b418-6c6841885cf4 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dabf8bc0-5de6-edce-e053-2995a90a73c9 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ef807d2-5d66-40c2-be3e-ff6176a35295 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c68f89b-1d34-4735-9631-817f012935d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43eb9e4f-1a46-46f7-9e9d-43e866963b37 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b2ec266-be5b-9265-e063-6294a90a10e3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20281fe6-7db9-4b33-8418-b25e6a5404ca (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b3b385-658d-5918-e053-2a95a90afcba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6cacd68-0f55-deb9-e053-6294a90aa266 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4d5c3142-b850-49b9-9f5c-81fe15ea7bfb (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e88bc86-d5e2-50ca-e053-2995a90a0f0e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:addccf96-cc60-6045-e053-2a95a90aaac0 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4a12048-181e-45ed-a382-f53096d1b689 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d125ea4-5430-5b4e-e054-00144ff88e88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6fbd554-9da7-40fd-87a5-2c4af2aa3e6c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76a8aedd-7853-4d3f-9a00-f8222f55bea8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9ddd1f24-3ebd-4307-bb23-6acd742cd140 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83510549-bd47-4969-aba0-c149a0fbb7f3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a645652-ae1f-3811-e054-00144ff8d46c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27 to 32 hours.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0458445b-e431-4c82-86b8-90373813c10a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0401570-a3b0-bef2-7365-c23dc952b8b6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a3f4bc9-cd6e-49b1-ab6c-982b70f51fd2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eef1c681-1972-4c3f-b4ba-cbb3388f397a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        Elimination Biotransformation of escitalopram is mainly hepatic, with a mean terminal half-life of about 27-32 hours.

  9. Projected row 549

    Medicine slug
    escitalopram
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    81
    Source count
    81
    Agreement rate
    1
    Recorded readings

    1. 12 L/kg

      Numeric value
      12
      Unit
      L/kg
      Source records
      81

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 81 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:102c3893-4fdc-40b3-bd83-775e292723d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d54a1cf-29cd-c485-e063-6394a90aeba3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e56e8d41-188c-5a6f-e053-2a95a90a70e6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:13bb8267-1cab-43e5-acae-55a4d957630a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0de88dad-d54c-4773-a5d6-a705e012973a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d31c02d0-81d9-4aa4-bde9-52135aa5a66d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f435d670-87ff-f226-e053-2a95a90ac0ee (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:900b7a2f-23e7-4c78-bd6e-549bbe09883e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3de8ea-b96b-456b-9336-69380fd2d058 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85b2f57e-53f3-4b93-9128-ad74cc34be4c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fc61822a-4058-343c-e053-6294a90af72c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de803217-6d32-4ef8-afe7-02462f37bf0c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53a7e974-9945-4e42-8395-b567bf9f1c4e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31ce0b82-58fe-44f3-8887-c55d8df1b773 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d9ba6c65-22bd-10c4-e053-2995a90ada2e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba6a0c20-4915-4164-a39e-ca67d652cbfd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64de12e0-c35f-4082-b902-ddbaee8158a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d75e3b97-1ead-4e7b-9ae3-3626aede1efd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:575d7755-0518-4d48-bb1a-4ad01321fde7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9b0b3c54-5bbc-4db9-9c69-00dac1347f24 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f75aabf8-f4a1-acd1-e053-6294a90ab9a6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:da7feb56-5f5a-7487-e053-2995a90a119e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45ed4d16-6358-40a1-9352-319e58f55e5d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d16a7510-c787-4c9b-818b-1ffbcc62b3c3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb30d1c5-2280-465f-84f4-4367ad5f1a31 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d58c448-4a6c-1b7d-e063-6294a90a7d03 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d143ec01-9445-42d5-a259-b0b5a7f9445f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f682f991-1807-176a-e053-2995a90a3dfa (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:068bb338-23f3-4278-958b-c34b40456024 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:155e973a-f4ff-4e5a-b937-09f1e106fe39 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83a642b9-acee-45d3-95a1-52a491b770fd (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5c00c4d3-8248-4321-adec-03886c0d0f7b (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ca5da44-403b-4c9f-9dde-f5a87866836d (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:84b2028d-eff4-434d-b71e-6a3c0812f625 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cb3f9af4-5bb4-48a8-b972-ff92cff1ea01 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f914fec5-4ce7-794d-e053-6294a90a7cc5 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ffc6ec3-830f-46bc-9b3f-7c42cefa39b2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1df5c652-7bad-4b07-b33b-333071bc2670 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a489600b-6ae0-edb7-e053-2a95a90a7d00 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c842ec12-8792-47a9-82ad-9edf99e549ba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:735a138b-fff3-4ed0-8a51-9090cf88ba30 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09894a38-4e3a-475d-96cd-c6c8ed87869a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:362327ce-2dde-f657-e063-6394a90a0b63 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1285841d-d9f8-49c6-9456-bf51c8e37271 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e3a3e36-fb2f-4d9b-bbcf-423bd97c9f88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5088d6cd-ec13-384d-e063-6394a90aee05 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0ff752d-cb30-4131-a7d6-cd66d8a47b1a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83fb7392-087d-4284-b27b-fa192e49dc21 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d2f83c1-8ffe-48f3-a084-150289001743 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4508226c-5623-41d3-8916-5f94ffdb8839 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0344290-6e12-46c4-a11c-5347a770adbe (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16a07596-2a89-4897-a829-529452ceb1e8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccbe97b5-da68-4fff-929a-240dd705fe6f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4966fd83-ee96-4f87-beb1-dd40d70de445 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f81e3858-f01e-1df6-e053-6394a90aef4f (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9f52332-8616-19d8-e053-2995a90ad753 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b7b0a6-481b-1f6f-e053-2a95a90a2d04 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3965ca55-a5ff-4ed0-940c-363d74683fab (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2fb28a40-037a-49a0-b418-6c6841885cf4 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dabf8bc0-5de6-edce-e053-2995a90a73c9 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0ef807d2-5d66-40c2-be3e-ff6176a35295 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9c68f89b-1d34-4735-9631-817f012935d7 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43eb9e4f-1a46-46f7-9e9d-43e866963b37 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b2ec266-be5b-9265-e063-6294a90a10e3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20281fe6-7db9-4b33-8418-b25e6a5404ca (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b3b385-658d-5918-e053-2a95a90afcba (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6cacd68-0f55-deb9-e053-6294a90aa266 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4d5c3142-b850-49b9-9f5c-81fe15ea7bfb (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e88bc86-d5e2-50ca-e053-2995a90a0f0e (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:addccf96-cc60-6045-e053-2a95a90aaac0 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f4a12048-181e-45ed-a382-f53096d1b689 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d125ea4-5430-5b4e-e054-00144ff88e88 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6fbd554-9da7-40fd-87a5-2c4af2aa3e6c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:76a8aedd-7853-4d3f-9a00-f8222f55bea8 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9ddd1f24-3ebd-4307-bb23-6acd742cd140 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83510549-bd47-4969-aba0-c149a0fbb7f3 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a645652-ae1f-3811-e054-00144ff8d46c (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The absolute bioavailability of citalopram is about 80% relative to an intravenous dose, and the volume of distribution of citalopram is about 12 L/kg.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0458445b-e431-4c82-86b8-90373813c10a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0401570-a3b0-bef2-7365-c23dc952b8b6 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8a3f4bc9-cd6e-49b1-ab6c-982b70f51fd2 (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eef1c681-1972-4c3f-b4ba-cbb3388f397a (opens source in a new tab)

        Escitalopram label

        Version not recorded · Effective date not recorded

        The volume of distribution of citalopram is about 12 L/kg.

  10. Projected row 550

    Medicine slug
    eslicarbazepine
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    10
    Source count
    10
    Agreement rate
    1
    Recorded readings

    1. 13 to 20 hours

      Numeric value
      13
      Unit
      hours
      Source records
      10

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 10 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22f29752-614f-caaf-b595-9deae8a3e3ff (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d279e461-2611-4f5c-938d-5d117612894f (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2067fb77-9657-44da-b430-02e8a4efacb5 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28efe9d2-9d7b-4a7c-8458-098456d06604 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:999b341f-fe13-4dd9-bb95-9b0d6a817c4c (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6200ae2e-ac4e-41b6-a1c3-0ea00703d7e3 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a3b3e50-6590-0040-e063-6294a90a84c1 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d0c9554-eaeb-4694-8089-00133fcadce3 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13-20 hours in adult epilepsy patients.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22d08671-ac0d-4e3d-8195-929bbb021125 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13-20 hours in adult epilepsy patients.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:190fccbc-da3f-b175-ac02-f2c4307a15c3 (opens source in a new tab)

        Eslicarbazepine label

        Version not recorded · Effective date not recorded

        The apparent half-life of eslicarbazepine in plasma was 13 to 20 hours in adult epilepsy patients.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=540

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy